Form 4: MindMed Executive Carrie Liao Sells Shares to Cover Tax Obligations

Carrie Liao, Chief Accounting Officer of Mind Medicine (MindMed) Inc., sold 2,352 common shares on September 25, 2024, to cover withholding tax obligations related to vested restricted stock units.

Summary

• Carrie Liao, the Chief Accounting Officer of Mind Medicine (MindMed) Inc., executed a sale of 2,352 common shares on September 25, 2024.
• The sale was conducted to satisfy withholding tax obligations associated with the settlement of vested restricted stock units.
• The transaction was executed under a Rule 10b5-1 plan adopted on May 29, 2024.
• The shares were sold at a weighted average price of $5.98, with individual transactions ranging from $5.95 to $6.07.
• Following the transaction, Liao directly owns 99,543 common shares.
• Liao has granted power of attorney to the company's executives to handle SEC filings.

Sentiment

Score: 6

Explanation: The document is neutral. It reports a routine transaction (share sale for tax obligations) by a company executive. The use of a 10b5-1 plan suggests transparency and pre-planning.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating it was planned and not based on immediate market conditions.

Industry Context

Sales of shares by company executives are a normal part of corporate governance. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on insider information.

Comparison to Industry Standards

• Executive share sales to cover tax obligations are common across publicly traded companies.
• Rule 10b5-1 plans are a standard tool used by executives to avoid accusations of insider trading, similar to practices at companies like Pfizer or Johnson & Johnson.

Stakeholder Impact

• The sale of shares by an executive could have a minor negative impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates this concern.

Key Dates